Source:http://linkedlifedata.com/resource/chebi/id/CHEBI:3207
| Predicate | Object |
|---|---|
| rdf:type | |
| skos:definition |
"A glucocorticoid steroid having a highly oxygenated pregna-1,4-diene structure. It is used mainly in the treatment of asthma and non-infectious rhinitis and for treatment and prevention of nasal polyposis." []
|
| skos:inScheme | |
| skos:prefLabel |
budesonide
|
| skos:altLabel |
11beta,21-dihydroxy-16alpha,17alpha-(butane-1,1-diyldioxy)pregna-1,4-diene-3,20-dione
|
| skos:notation |
ChemIDplus:51333-22-3 "CAS Registry Number",
CiteXplore:21616561 "PubMed citation",
DrugBank:DB01222 "DrugBank",
KEGG DRUG:51333-22-3 "CAS Registry Number",
KEGG DRUG:D00246 "KEGG DRUG",
Patent:DE2323215 "Patent",
Patent:US3929768 "Patent",
Wikipedia:Budesonide "Wikipedia"
|
| skos:broader | |
| skos:relatedSynonym |
C25H34O6,
budesonide,
(11beta,16alpha)-16,17-(Butylidenebis(oxy))-11,21-dihydroxypregna-1,4-diene-3,20-dione,
[H][C@@]12CCC3=CC(=O)C=C[C@]3(C)[C@@]1([H])[C@@H](O)C[C@@]1(C)[C@@]2([H])C[C@H]2OC(CCC)O[C@@]12C(=O)CO,
InChI=1S/C25H34O6/c1-4-5-21-30-20-11-17-16-7-6-14-10-15(27)8-9-23(14,2)22(16)18(28)12-24(17,3)25(20,31-21)19(29)13-26/h8-10,16-18,20-22,26,28H,4-7,11-13H2,1-3H3/t16-,17-,18-,20+,21?,22+,23-,24-,25+/m0/s1,
InChIKey=VOVIALXJUBGFJZ-KWVAZRHASA-N
|